Yimiao Feng

Yimiao Feng

Auto-generated profile, based on publicly available information

Yimiao Feng

School of Information Science and Technology, ShanghaiTech University, Shanghai, China and Lingang Laboratory, Shanghai, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
YFYimiao Feng
Yimiao Feng
YLYahui Long
Yahui Long
HWHe Wang
He Wang
YOYang Ouyang
Yang Ouyang
QLQuan Li
Quan Li
ZJZheng Jie
Zheng Jie
Synthetic lethality (SL) is a gold mine of anticancer drug targets, exposing cancer-specific dependencies of cellular survival. To complement resource-intensive experimental screening, many machine learning methods for SL prediction have emerged recently. However, a comprehensive benchmarking is lacking. This study systematically benchmarks 12 recent machine learning methods for SL prediction, assessing their performance across diverse data splitting scenarios, negative sample ratios, and negative sampling techniques, on both classification and ranking tasks. We observe that all the methods can perform significantly better by improving data quality, e.g., excluding computationally derived SLs from training and sampling negative labels based on gene expression. Among the methods, SLMGAE performs the best. Furthermore, the methods have limitations in realistic scenarios such as cold-start independent tests and context-specific SLs. These results, together with source code and datasets made freely available, provide guidance for selecting suitable methods and developing more powerful techniques for SL virtual screening.

25 April 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
STSiyu Tao
Siyu Tao
YFYimiao Feng
Yimiao Feng
YYYang Yang
Yang Yang
MWMin Wu
Min Wu
ZJZheng Jie
Zheng Jie
Synthetic lethality (SL) offers a promising approach for targeted cancer therapies. Current SL prediction models heavily rely on extensive labeled data for specific cell lines to accurately identify SL pairs. However, a major limitation is the scarcity of SL labels across most cell lines, which makes it challenging to predict SL pairs for target cell lines with limited or even no available labels in real-world scenarios. Furthermore, gene interactions could be opposite between training and test cell lines, i.e. SL vs. non-SL, which further aggravates the challenge of generalization among cell lines. A promising strategy is to transfer knowledge learned from cell lines with relatively abundant SL labels to those with limited SL labels for the discovery of novel SL pairs, i.e., cell line-adapted SL prediction. Here, we propose MiT4SL, a multi-omics triplet representation learning model for cell line-adapted SL prediction. The core idea of MiT4SL is to model cell lineage information as embeddings, which are generated by combining a protein-protein interaction network representation tailored to each cell line with the corresponding protein sequence embeddings. We then combine these cell line embeddings with gene pair representations derived from a biomedical knowledge graph and protein sequences. This triplet representation learning strategy enables MiT4SL to capture both shared biological mechanisms across cell lines and those unique to each cell line, effectively mitigating distribution shift and improving generalization to target cell lines. Additionally, explicit cell line embeddings provide the necessary signals for MiT4SL to effectively differentiate between cell line contexts, enabling it to adjust predictions and mitigate possible label conflicts for the same gene pair across different cell lines. Experimental results across various cell line-adapted scenarios show that MiT4SL outperforms six state-of-the-art models. To the best of our knowledge, MiT4SL is the first deep learning model designed specifically for cancer cell line-adapted SL prediction. Availability: The code of our work is available at https://github.com/JieZheng-ShanghaiTech/MiT4SL .

6 October 2025 in IEEE Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
STSiyu Tao
Siyu Tao
YYYang Yang
Yang Yang
XLXin Liu
Xin Liu
YFYimiao Feng
Yimiao Feng
ZJZheng Jie
Zheng Jie
Predicting biomedical interactions is crucial for understanding various biological processes and drug discovery. Graph neural networks (GNNs) are promising in identifying novel interactions when extensive labeled data are available. However, labeling biomedical interactions is often time-consuming and labor-intensive, resulting in low-data scenarios. Furthermore, distribution shifts between training and test data in real-world applications pose a challenge to the generalizability of GNN models. Recent studies suggest that pre-training GNN models with self-supervised learning on unlabeled data can enhance their performance in predicting biomedical interactions. Here, we propose LukePi, a novel self-supervised pre-training framework that pre-trains GNN models on biomedical knowledge graphs (BKGs). LukePi is trained with two self-supervised tasks: topology-based node degree classification and semantics-based edge recovery. The former is to predict the degree of a node from its topological context and the latter is to infer both type and existence of a candidate edge by learning semantic information in the BKG. By integrating the two complementary tasks, LukePi effectively captures the rich information from the BKG, thereby enhancing the quality of node representations. We evaluate the performance of LukePi on two critical link prediction tasks: predicting synthetic lethality and drug-target interactions, using four benchmark datasets. In both distribution-shift and low-data scenarios, LukePi significantly outperforms 22 baseline models, demonstrating the power of the graph pre-training strategy when labeled data are sparse.

13 February 2025 in bioRxiv
Verified
Preprint
Open access
STSiyu Tao
Siyu Tao
YYYang Yang
Yang Yang
XLXin Liu
Xin Liu
YFYimiao Feng
Yimiao Feng
ZJZheng Jie
Zheng Jie
Predicting biomedical interactions is crucial for understanding various biological processes and drug discovery. Graph neural networks (GNNs) are promising in identifying novel interactions when extensive labeled data are available. However, labeling biomedical interactions is often time-consuming and labor-intensive, resulting in low-data scenarios. Furthermore, distribution shifts between training and test data in real-world applications pose a challenge to the generalizability of GNN models. Recent studies suggest that pre-training GNN models with self-supervised learning on unlabeled data can enhance their performance in predicting biomedical interactions. Here, we propose LukePi, a novel self-supervised pre-training frame-work that pre-trains GNN models on biomedical knowledge graphs (BKGs). LukePi is trained with two self-supervised tasks: topology-based node degree classification and semantics-based edge recovery. The former is to predict the degree of a node from its topological context and the latter is to infer both type and existence of a candidate edge by learning semantic information in the BKG. By integrating the two complementary tasks, LukePi effectively captures the rich information from the BKG, thereby enhancing the quality of node representations. We evaluate the performance of LukePi on two critical link prediction tasks: predicting synthetic lethality and drug-target interactions, using four benchmark datasets. In both distribution-shift and low-data scenarios, LukePi significantly outperforms 15 baseline models, demonstrating the power of the graph pre-training strategy when labeled data are sparse.

13 February 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
YFYimiao Feng
Yimiao Feng
YLYahui Long
Yahui Long
HWHe Wang
He Wang
YOYang Ouyang
Yang Ouyang
QLQuan Li
Quan Li
ZJZheng Jie
Zheng Jie